Related Experiment Videos
Advances in lymphoma treatment
1Department of Medicine, University of Zimbabwe, Avondale, Harare.
The Central African Journal of Medicine
|March 1, 1992
Summary
Significant progress in lymphoma treatment has been made, with effective combination regimens achieving high remission rates in Hodgkin
Area of Science:
- Hematology
- Oncology
- Clinical Medicine
Background:
- Lymphoma management has seen substantial advancements over the last 30 years.
- Early breakthroughs, like the MOPP regimen for Hodgkin's disease, significantly improved outcomes.
Purpose of the Study:
- To review the progress in lymphoma management over the past three decades.
- To highlight therapeutic successes and ongoing challenges in treating various lymphoma subtypes.
Main Methods:
- Review of historical and recent treatment strategies for lymphoma.
- Analysis of remission rates and survival data for different lymphoma types.
Main Results:
- Hodgkin's disease management has advanced, with combination therapies yielding up to 80% remission rates.
- Aggressive non-Hodgkin's lymphomas show high response rates (70-80%) to intensive chemotherapy.
- Indolent lymphomas remain largely incurable, and lymphoblastic lymphoma presents ongoing challenges.
Conclusions:
- While significant strides have been made, particularly in Hodgkin's disease and aggressive lymphomas, challenges persist.
- Bone marrow transplantation and biological response modifiers represent important recent developments.
- The ongoing challenge is to develop treatments with improved survival and reduced toxicity.